 |
| Hospital Surgical Disinfectants Market Growth |
The global Hospital Surgical Disinfectants Market is estimated to be valued at US$ 3.51 Bn in 2023 and is expected to
exhibit a CAGR of 9.6% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Overview:
Hospital surgical disinfectants are antimicrobial-based products used for
disinfecting hands, skin and medical instruments in hospitals settings. These
disinfectant products helps prevent the spread of hospital-acquired infections
by destroying or inhibiting the growth of microorganisms on inanimate objects.
The most commonly used hospital surgical disinfectants includes skin
disinfectants, instrument disinfectants, and surface disinfectants. With
increasing number of surgeries and prevalence of hospital-acquired infections
worldwide, the demand for effective disinfectant products is growing in
hospital settings.
Market key trends:
One of the key trends in hospital surgical disinfectants market is growing
adoption of non-alcohol based disinfectants. Majority of available hand
disinfectants contain alcohol as active ingredient which causes skin dryness
and irritation with frequent use. This has led to increasing demand for
alcohol-free, gentle hand disinfectants containing ingredients like Benzalkonium
chloride or triclosan. Companies are focused on launching novel non-alcohol
based disinfectants specially formulated for healthcare workers with frequent
hand hygiene requirements. For instance, in 2020, Ecolab launched Opticlean
Plus, an advanced non-alcohol based surgical hand antiseptic for repeated hand
scrubbing in healthcare facilities.
Porter’s Analysis
Threat of new entrants: The Hospital
Surgical Disinfectants Market Growth requires significant capital
investments for R&D, manufacturing facilities and marketing. Established
brands have strong customer loyalty and regulations acts as a barrier for new
players.
Bargaining power of buyers: The buyers have moderate bargaining power due to
presence of many established brands and product differentiation. However,
importance of infection control increases their dependence on disinfectant
products.
Bargaining power of suppliers: The suppliers have low to moderate bargaining
power due to availability of substitute raw materials and chemicals.
Regulations ensure quality standards.
Threat of new substitutes: Other alternatives for disinfection include
alcohols, bleach, etc. but established disinfectants continue to have
advantages of being skin-friendly and with broad-spectrum efficacy.
Competitive rivalry: Intense due to presence of global and regional vendors
competing on product quality, innovation and pricing. Brand reputation and
customer loyalty are also differentiating factors.
Key Takeaways
The global Hospital Surgical Disinfectants Market is expected to witness high
growth, exhibiting CAGR of 9.6% over
the forecast period, due to increasing prevalence of hospital-acquired
infections and rising awareness about infection control measures.
North
America dominates the global hospital surgical disinfectants market due to
advanced healthcare infrastructure and stringent regulations regarding
infection control and sterilization. Asia Pacific is expected to witness
fastest growth owing to growing medical tourism, rising healthcare expenditures
and increasing surgical procedures in the region.
Key players
operating in the hospital surgical disinfectants market are 3M Company, Reckitt
Benckiser Group plc, Ecolab Inc., Steris plc, Cardinal Health, Becton,
Dickinson and Company, Kimberly-Clark Corporation, Bio-Cide International Inc.,
Shandong Weigao Group Medical Polymer Company Limited, Carenow Medical Pvt.
Ltd., B.Braun Melsungen AG, HARTMANN GROUP, Merck KGaA, Entaco Ltd., Medalkan,
Medichem S.A., Ruhof Healthcare, Clinicept Healthcare, Integra LifeSciences Holdings
Corporation, Micro-Scientific, LLC.
Read More: https://www.pressreleasebulletin.com/hospital-surgical-disinfectants-market-scope/